Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in Renal Transplantation
NCT01586845Phase 3Withdrawn
- Sponsor
- Aurinia
- Start
- Mar 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of voclosporin in kidney transplant rejection (2 arms), sponsored by Aurinia. Primary endpoint: Efficacy failure at 12 months. Planned start Mar 2013; status: withdrawn.
02
Drugs
voclosporin
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01586845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586845.